James J Strain1. 1. a Department of Psychiatry , Icahn School of Medicine at Mount Sinai , New York , NY , USA.
Abstract
OBJECTIVES: This paper focuses on the psychobiology of stress, depression, adjustment disorders (ADs), and resilience. Since the ADs fall under the rubric in DSM-5 of Trauma and Stressor-Related Disorders, essentials of the psychobiology of stress-response syndromes will be reviewed. METHODS: A narrative review of the psychobiology of stress-response syndromes is undertaken, and the implications for our understanding of ADs are discussed. RESULTS: Advances in our understanding of the psychobiology of stress-response syndromes provide an important foundation for understanding ADs, and for conceptualizing their diagnosis, as well as issues of resilience. CONCLUSIONS: Future investigations of the psychobiology of trauma- and stressor-related disorders may shed additional light on ADs, and ultimately improve their treatment.
OBJECTIVES: This paper focuses on the psychobiology of stress, depression, adjustment disorders (ADs), and resilience. Since the ADs fall under the rubric in DSM-5 of Trauma and Stressor-Related Disorders, essentials of the psychobiology of stress-response syndromes will be reviewed. METHODS: A narrative review of the psychobiology of stress-response syndromes is undertaken, and the implications for our understanding of ADs are discussed. RESULTS: Advances in our understanding of the psychobiology of stress-response syndromes provide an important foundation for understanding ADs, and for conceptualizing their diagnosis, as well as issues of resilience. CONCLUSIONS: Future investigations of the psychobiology of trauma- and stressor-related disorders may shed additional light on ADs, and ultimately improve their treatment.
Authors: Ju-Yu Yen; Huang-Chi Lin; Wei-Po Chou; Tai-Ling Liu; Chih-Hung Ko Journal: Int J Environ Res Public Health Date: 2019-08-31 Impact factor: 3.390
Authors: Pia Koudouovoh-Tripp; Katharina Hüfner; Jonas Egeter; Christina Kandler; Johannes M Giesinger; Sieghart Sopper; Christian Humpel; Barbara Sperner-Unterweger Journal: J Neuroimmune Pharmacol Date: 2020-08-05 Impact factor: 4.147